Implantation and imaging of BioXmark- and Gold-Markers in resection specimen of patients with adenocarcinoma of the pancreas

• Conditions: C25.9; Pancreas, unspecified

• Registration Number: DRKS00009725
• Lead Sponsor: niversitätsklinikum Carl Gustav Carus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01-05
• Study Completion: 2017-07-31
• Results First Posted: 2019-05-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Patients with primary resectable adenocarcinoma of the pancreas undergoing oncologic surgery
- oral and written consent

Exclusion Criteria

- neoadjuvant therapy e.g. chemotherapy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility to implant both markers (BioXmark, gold marker)<br>

Secondary Outcome Measures

Name	Time	Method
Visibility of both markers on CT, MRI and kV/MV-x-ray imaging, Reliable pathologic assessment of the resection specimen after implantation of the markers